Impact of the transcriptional regulator, Ace2, on the Candida glabrata secretome
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Candida glabrata is a major fungal pathogen of humans, and the virulence of C. glabrata is increased by inactivation of the transcription factor, Ace2. Our previous examination of the effects of Ace2 inactivation upon the intracellular proteome suggested that the hypervirulence of C. glabrata ace2 mutants might be caused by differences in the secretome. Therefore in this study we have characterised the C. glabrata secretome and examined the effects of Ace2 inactivation upon this extracellular proteome. We have identified 31 distinct proteins in the secretome of wild‐type C. glabrata cells by MS/MS of proteins that were precipitated from the growth medium and enriched by affinity chromatography on concanavalin A. Most of these proteins are predicted to be cell wall proteins, cell wall modifying enzymes and aspartyl proteinases. The endochitinase Cts1 and the endoglucanase Egt2 were not detected in the C. glabrata secretome following Ace2 inactivation. This can account for the cell separation defect of C. glabrata ace2 cells. Ace2 inactivation also resulted in the detection of new proteins in the C. glabrata secretome. The release of such proteins might contribute to the hypervirulence of ace2 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738 · cited 1×
“Life-threatening fungal infections are on the increase [1, 2].”
BackgroundViscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601
Pfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J., Messer, S. A., & The SENTRY Participant Group (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3254-3259.2001 · Cited by 521
Hydrolytic enzymes as virulence factors of Candida albicans
Schaller, M., Borelli, C., Korting, H. C., & Hube, B. (2005) · Mycoses · doi:10.1111/j.1439-0507.2005.01165.x · Cited by 506
Kaur, R., Ma, B., & Cormack, B. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611195104 · Cited by 284 · cited 1×
“Cormack and co-workers have demonstrated that a family of subtelomerically located adhesins play crucial roles in adherence to mammalian epithelial cells [16, 17], their expression is activated by nicotinic acid limitation [18] and at least one of them Epa1, is processed by members of a yapsin-like family of proteases…”
BackgroundA yeast by any other name: Candida glabrata and its interaction with the host
Kaur, R., Domergue, R., Zupancic, M. L., & Cormack, B. P. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.012 · Cited by 271
Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata
Castaño, I., Pan, S., Zupancic, M., Hennequin, C., Dujon, B., & Cormack, B. P. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04465.x · Cited by 188
Infection-related gene expression in Candida albicans
Brown, A. J. P., Odds, F. C., & Gow, N. A. R. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.04.001 · Cited by 148
Self-citationProteomics for the analysis of the Candida albicans biofilm lifestyle
Thomas, D. P., Bachmann, S. P., & Lopez‐Ribot, J. L. (2006) · PROTEOMICS · doi:10.1002/pmic.200600332 · Cited by 117
Kamran, M., Calcagno, A.-M., Findon, H., Bignell, E., Jones, M. D., Warn, P., Hopkins, P., Denning, D. W., Butler, G., Rogers, T., et al. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.546-552.2004 · Cited by 75 · cited 6×
“glabrata strains ACG4 (his3 trp1 PScHOP1::tetR::GAL4AD::TRP1 [29]), HLS121 (his3::URA3 ura3 trp1 ace2::HIS3 (pKH355 [ACE2 TRP1]) [21]) and HLS122 (his3::URA3 ura3 trp1 ace2::HIS3 (pCgACT-14 [TRP1]) [21]) have been described previously.”
BackgroundSelf-citationMacCallum, D. M., Findon, H., Kenny, C. C., Butler, G., Haynes, K., & Odds, F. C. (2006) · Infection and Immunity · doi:10.1128/iai.00817-06 · Cited by 45 · cited 1×
“glabrata ace2 null mutants display enhanced virulence compared with wild type controls [21, 32].”
BackgroundSelf-citation
Cited by
Candida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690
“glabrata Ace2 homologs also play important roles in biofilm formation (68, 95).”
BackgroundCandida glabrata: A review of its features and resistance
Rodrigues, C. F., Silva, S., & Henriques, M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2009-3 · Cited by 268
Roetzer, A., Gabaldón, T., & Schüller, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02102.x · Cited by 154
“Stead et al. (2010) found that lack of CgAce2 also changes the secretome of C. glabrata, which might contribute to its hypervirulence.”
BackgroundCandida glabrata Biofilms: How Far Have We Come?
Rodrigues, C., Rodrigues, M., Silva, S., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010011 · Cited by 129
Sorgo, A. G., Heilmann, C. J., Dekker, H. L., Bekker, M., Brul, S., de Koster, C. G., de Koning, L. J., & Klis, F. M. (2011) · Eukaryotic Cell · doi:10.1128/ec.05011-11 · Cited by 120
Metadata
- Authors
- Stead, D. A., Walker, J., Holcombe, L., Gibbs, S. R. S., Yin, Z., Selway, L., Butler, G., Brown, A. J. P., & Haynes, K.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2010-01
- Volume
- 10
- Issue
- 2
- Pages
- 212-223
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2031863436
- Cited by
- 29
- References
- 11
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.